Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 792.5133 USD 3.22%
Market Cap: 752.3B USD
Have any thoughts about
Eli Lilly and Co?
Write Note

Intrinsic Value

The intrinsic value of one LLY stock under the Base Case scenario is 334.4238 USD. Compared to the current market price of 792.5133 USD, Eli Lilly and Co is Overvalued by 58%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LLY Intrinsic Value
334.4238 USD
Overvaluation 58%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Eli Lilly and Co

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
LLY
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for LLY cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about LLY?
Bearish
Neutral
Bullish

Fundamental Analysis

792.5133 USD
+3.22%
+3.22%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Eli Lilly and Co
US
Pharmaceuticals
Market Cap
752.8B USD
IPO
Jul 9, 1970
Employees
35 000
United States of America
Market Cap
752.8B USD
Industry
Pharmaceuticals
IPO
Jul 9, 1970
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Eli Lilly and Co

Provide an overview of the primary business activities
of Eli Lilly and Co.

What unique competitive advantages
does Eli Lilly and Co hold over its rivals?

What risks and challenges
does Eli Lilly and Co face in the near future?

Has there been any significant insider trading activity
in Eli Lilly and Co recently?

Summarize the latest earnings call
of Eli Lilly and Co.

What significant events have occurred
in Eli Lilly and Co over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Eli Lilly and Co.

Provide P/S
for Eli Lilly and Co.

Provide P/E
for Eli Lilly and Co.

Provide P/OCF
for Eli Lilly and Co.

Provide P/FCFE
for Eli Lilly and Co.

Provide P/B
for Eli Lilly and Co.

Provide EV/S
for Eli Lilly and Co.

Provide EV/GP
for Eli Lilly and Co.

Provide EV/EBITDA
for Eli Lilly and Co.

Provide EV/EBIT
for Eli Lilly and Co.

Provide EV/OCF
for Eli Lilly and Co.

Provide EV/FCFF
for Eli Lilly and Co.

Provide EV/IC
for Eli Lilly and Co.

Show me price targets
for Eli Lilly and Co made by professional analysts.

What are the Revenue projections
for Eli Lilly and Co?

How accurate were the past Revenue estimates
for Eli Lilly and Co?

What are the Net Income projections
for Eli Lilly and Co?

How accurate were the past Net Income estimates
for Eli Lilly and Co?

What are the EPS projections
for Eli Lilly and Co?

How accurate were the past EPS estimates
for Eli Lilly and Co?

What are the EBIT projections
for Eli Lilly and Co?

How accurate were the past EBIT estimates
for Eli Lilly and Co?

Compare the revenue forecasts
for Eli Lilly and Co with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Eli Lilly and Co and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Eli Lilly and Co against its competitors.

Analyze the profit margins
(gross, operating, and net) of Eli Lilly and Co compared to its peers.

Compare the P/E ratios
of Eli Lilly and Co against its peers.

Discuss the investment returns and shareholder value creation
comparing Eli Lilly and Co with its peers.

Analyze the financial leverage
of Eli Lilly and Co compared to its main competitors.

Show all profitability ratios
for Eli Lilly and Co.

Provide ROE
for Eli Lilly and Co.

Provide ROA
for Eli Lilly and Co.

Provide ROIC
for Eli Lilly and Co.

Provide ROCE
for Eli Lilly and Co.

Provide Gross Margin
for Eli Lilly and Co.

Provide Operating Margin
for Eli Lilly and Co.

Provide Net Margin
for Eli Lilly and Co.

Provide FCF Margin
for Eli Lilly and Co.

Show all solvency ratios
for Eli Lilly and Co.

Provide D/E Ratio
for Eli Lilly and Co.

Provide D/A Ratio
for Eli Lilly and Co.

Provide Interest Coverage Ratio
for Eli Lilly and Co.

Provide Altman Z-Score Ratio
for Eli Lilly and Co.

Provide Quick Ratio
for Eli Lilly and Co.

Provide Current Ratio
for Eli Lilly and Co.

Provide Cash Ratio
for Eli Lilly and Co.

What is the historical Revenue growth
over the last 5 years for Eli Lilly and Co?

What is the historical Net Income growth
over the last 5 years for Eli Lilly and Co?

What is the current Free Cash Flow
of Eli Lilly and Co?

Discuss the annual earnings per share (EPS)
trend over the past five years for Eli Lilly and Co.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eli Lilly and Co

Current Assets 31.4B
Cash & Short-Term Investments 3.5B
Receivables 12.1B
Other Current Assets 15.8B
Non-Current Assets 44.2B
Long-Term Investments 3.2B
PP&E 16.2B
Intangibles 12.3B
Other Non-Current Assets 12.5B
Current Liabilities 24.7B
Accounts Payable 2.9B
Accrued Liabilities 14.1B
Other Current Liabilities 7.7B
Non-Current Liabilities 36.7B
Long-Term Debt 29B
Other Non-Current Liabilities 7.6B
Efficiency

Earnings Waterfall
Eli Lilly and Co

Revenue
40.9B USD
Cost of Revenue
-7.8B USD
Gross Profit
33.1B USD
Operating Expenses
-18.6B USD
Operating Income
14.4B USD
Other Expenses
-6.1B USD
Net Income
8.4B USD

Free Cash Flow Analysis
Eli Lilly and Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

LLY Profitability Score
Profitability Due Diligence

Eli Lilly and Co's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
Positive Operating Income
72/100
Profitability
Score

Eli Lilly and Co's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

LLY Solvency Score
Solvency Due Diligence

Eli Lilly and Co's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
High D/E
53/100
Solvency
Score

Eli Lilly and Co's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LLY Price Targets Summary
Eli Lilly and Co

Wall Street analysts forecast LLY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LLY is 1 011.1037 USD with a low forecast of 707 USD and a high forecast of 1 312.5 USD.

Lowest
Price Target
707 USD
11% Downside
Average
Price Target
1 011.1037 USD
28% Upside
Highest
Price Target
1 312.5 USD
66% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LLY?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Dec 23, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for LLY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LLY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

LLY News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one LLY stock?

The intrinsic value of one LLY stock under the Base Case scenario is 334.4238 USD.

Is LLY stock undervalued or overvalued?

Compared to the current market price of 792.5133 USD, Eli Lilly and Co is Overvalued by 58%.

Back to Top